Page 9 - Respir Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Respir med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Respir Med Today - Breaking & Trending Today

Correction to Lancet Respir Med 2023; published online Jan 23. https://doi.org/10.1016/S2213-2600(22)00492-1

Menzies-Gow A, Wechsler ME, Brightling CE, et al. Long-term safety and efficacy of
tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised,
placebo-controlled extension study. Lancet Respir Med 2023; published online Jan 23.
https://doi.org/10.1016/S2213-2600(22)00492-1 In this Article s appendix, table s7
should have read “n=840” participants in the all tezepelumab group for the pooled
NAVIGATOR and SOURCE population and the last line of the legend for figure s2 should
have read “(E; data from D were not included; same as the placebo then tezepelumab
group)”. ....

East Sussex , United Kingdom , Respir Med ,

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Tezepelumab treatment was well tolerated for up to 2 years and resulted in sustained,
clinically meaningful reductions in asthma exacerbations in individuals with severe,
uncontrolled asthma. These findings are consistent with previous randomised, placebo-controlled
studies and show the long-term safety and sustained efficacy of tezepelumab in individuals
with severe, uncontrolled asthma. ....

East Sussex , United Kingdom , Panettieri Jr , Gtex Consortium , Drug Administration , Nord Trondelag Health Study , Global Initiative For Asthma , Respir Med , Englj Med , Opin Ther Targets , Allergy Clin Immunol , Respiratory Questionnaire , Asthma Allergy ,

Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?

Usual interstitial pneumonia (UIP) is characterised by a distinctive morphological
and radiological appearance that was considered the pathognomonic hallmark of idiopathic
pulmonary fibrosis (IPF). However, this peculiar lung remodelling pattern is also
seen in other fibrotic interstitial lung diseases, including hypersensitivity pneumonitis,
and connective tissue diseases. In this Personal View, we advocate the designation
of a UIP pattern as a single, discrete diagnostic entity, amalgamating its primary
form and secondary processes in disorders such as hypersensitivity pneumonitis (hypersensitivity
pneumonitis with UIP), rheumatoid arthritis (rheumatoid arthritis with UIP), and others. ....

United States , Mashonaland East , United Kingdom , King Jr , Clin Rheumatol , Roy Chowdhury , American Thoracic Society European Respiratory , European Respiratory Society American Thoracic , European Respiratory Society , American Thoracic Society , American Thoracic , Arthritis Rheum , Bone Spine , European Respiratory , Rev Respir Med , Englj Med , Envisia Genomic Classifier , Respir Med , Death Discov ,

Tomato flu: misnomer for a common disease? – Authors' reply

We thank Saurav Paul and colleagues for their response to our Correspondence.1 Our
original Correspondence was written at a time when scarce scientific information was
available on this uncommon presentation referred to as tomato flu; hence we included
media reports in our references. The main aim of our Correspondence was to increase
awareness of this unusual presentation, based on the information available to us at
the time; however, we appreciate that discussion of the COVID-19 pandemic in relation
to tomato flu might have caused unnecessary concern. ....

Hong Kong , Genet Evol , Vivek Chavda , Saurav Paul , Lancet Reg Health West Pac , Elsevier Ltd , Respir Med , Reg Health West Pac , Med Surg , Stomatol Oral Maxillofac ,

The future of paediatric acute respiratory distress syndrome

Heterogeneity is a familiar concept to paediatric intensive care physicians, because
patients, pathologies, and treatments vary both within the paediatric intensive care
unit (PICU) and within a given disease process. Paediatric acute respiratory distress
syndrome (ARDS) typifies this problem. Children with ARDS vary in terms of age (and
therefore lung development), underlying cause (pneumonia, sepsis, or trauma), pre-existing
comorbid conditions, and baseline immunological state. There is not one pathway by
which ARDS occurs or manifests, as indicated by the identification of hyperinflammatory
and hypoinflammatory subtypes in adults and children. ....

Martin Kneyber , Respir Med , Lancet Respiratory Medicine ,